Role of MicroRNAs in Bone Pathology during Chikungunya Virus Infection

Enakshi Roy1, Siddappa N Byrareddy2,3,4, St Patrick Reid1

  • 1Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha, NE 68198-5900, USA.

Viruses
|October 29, 2020
PubMed

Insights

Chikungunya virus (CHIKV) infection can cause severe joint pain and bone issues. This review explores how microRNAs (miRNAs) impact bone health during CHIKV infection, potentially revealing new therapeutic targets.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Chikungunya virus (CHIKV) causes fever, rash, and severe joint pain, with 30-40% experiencing persistent polyarthritis.
  • Current treatments and vaccines for CHIKV are lacking, and the mechanisms of CHIKV-induced bone pathology remain unclear.
  • MicroRNAs (miRNAs) are key regulators of cellular functions and have been implicated in bone homeostasis and various bone diseases.

Purpose of the Study:

  • To review the altered expression of miRNAs during Chikungunya virus pathogenesis.
  • To explore the potential role of miRNAs in regulating bone homeostasis during CHIKV infection.
  • To identify potential miRNA biomarkers or therapeutic targets for CHIKV-induced bone pathology.

Main Methods:

  • Literature review of studies on CHIKV pathogenesis and miRNA expression.
  • Analysis of existing research on miRNA regulation of bone homeostasis.
  • Synthesis of information on signaling pathways targeted by miRNAs in bone remodeling and CHIKV infection.

Main Results:

  • CHIKV infection alters the expression of specific miRNAs.
  • These altered miRNAs may play a significant role in modulating bone homeostasis during CHIKV infection.
  • Understanding miRNA-targeted pathways could illuminate CHIKV-induced bone pathology.

Conclusions:

  • MicroRNAs are critically involved in the host response to CHIKV infection and its impact on bone health.
  • Further research into miRNA-mediated mechanisms could lead to novel diagnostic biomarkers and therapeutic strategies for Chikungunya fever complications.
  • Targeting specific miRNAs offers a promising avenue for managing CHIKV-related bone pathology.